Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Jan. 31, 2025	Jan. 31, 2024
Cash flows from operating activities:
Net earnings	$ 565	$ 622
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	197	205
Stock-based compensation expense	192	177
Restructuring and other charges	70	63
Deferred taxes on earnings	(23)	(5)
Other, net	35	(20)
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	966	446
Inventory	(751)	(47)
Accounts payable	(397)	(744)
Net investment in leases related to integrated financing	2	(62)
Taxes on earnings	12	49
Restructuring and other	(74)	(87)
Other assets and liabilities	(420)	(476)
Net cash provided by operating activities	374	121
Cash flows from investing activities:
Investment in property, plant, equipment and purchased intangible	(302)	(158)
Purchases of available-for-sale securities and other investments	(3)	0
Maturities and sales of available-for-sale securities and other investments	5	0
Collateral posted for derivative instruments	0	(70)
Net cash used in investing activities	(300)	(228)
Cash flows from financing activities:
Proceeds from short-term borrowings with original maturities less than 90 days, net	0	100
Proceeds from debt, net of issuance costs	82	92
Payment of debt and associated costs	(50)	(49)
Stock-based award activities and others	(92)	(76)
Repurchase of common stock	(100)	(500)
Cash dividends paid	(273)	(275)
Net cash used in financing activities	(433)	(708)
Decrease in cash, cash equivalents and restricted cash	(359)	(815)
Cash, cash equivalents and restricted cash at beginning of period	3,253	3,232
Cash, cash equivalents and restricted cash at end of period	$ 2,894	$ 2,417